A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors
Recruiting · NCT06804824 · Registry updated 2026-03-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-159642 in Participants With Advanced Solid Tumors | Advanced Solid Tumors | Recruiting | Phase 1 | 2026-03-18 | NCT06804824 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Vividion Therapeutics, Inc. | 4 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Clinical Research South Australia (CRSA) | Adelaide | Australia | 1 |
| Linear Clinical | Nedlands | Australia | 1 |
| NEXT Austin | Austin | United States | 10 |
| NEXT Dallas | Irving | United States | 18 |
| NEXT San Antonio | San Antonio | United States | 1 |
| NEXT Virginia | Fairfax | United States | 83 |
| START Mid West | Grand Rapids | United States | 1 |
| START Mountain | Ogden | United States | 1 |
| START San Antonio | San Antonio | United States | 30 |